Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between Hypocretin-1 and Amyloid-β42 Cerebrospinal Fluid Levels in Alzheimer’s Disease and Healthy Controls
Diane Slats, Jurgen A.H.R. Claassen, Gert Jan Lammers, et al.
Current Alzheimer Research (2012) Vol. 9, Iss. 10, pp. 1119-1125
Closed Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Sleep and Alzheimer's disease
Laure Peter‐Derex, Pierre Yammine, Hélène Bastuji, et al.
Sleep Medicine Reviews (2014) Vol. 19, pp. 29-38
Closed Access | Times Cited: 391
Orexinergic System Dysregulation, Sleep Impairment, and Cognitive Decline in Alzheimer Disease
Claudio Liguori, Andrea Romigi, Marzia Nuccetelli, et al.
JAMA Neurology (2014) Vol. 71, Iss. 12, pp. 1498-1498
Closed Access | Times Cited: 300
Association of Excessive Daytime Sleepiness With Longitudinal β-Amyloid Accumulation in Elderly Persons Without Dementia
Diego Z. Carvalho, Erik K. St. Louis, David S. Knopman, et al.
JAMA Neurology (2018) Vol. 75, Iss. 6, pp. 672-672
Open Access | Times Cited: 175
Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease
Jonathan Cedernaes, Ricardo S. Osorio, Andrew W. Varga, et al.
Sleep Medicine Reviews (2016) Vol. 31, pp. 102-111
Open Access | Times Cited: 174
Sleep in Alzheimer's Disease–Beyond Amyloid
Jerrah K. Holth, Tirth K. Patel, David M. Holtzman
Neurobiology of Sleep and Circadian Rhythms (2016) Vol. 2, pp. 4-14
Open Access | Times Cited: 145
The sleep–wake Cycle and Alzheimer’s Disease: What do We know?
Miranda M. Lim, Jason R. Gerstner, David M. Holtzman
Neurodegenerative Disease Management (2014) Vol. 4, Iss. 5, pp. 351-362
Open Access | Times Cited: 138
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease
Claudio Liguori, Marzia Nuccetelli, Francesca Izzi, et al.
Neurobiology of Aging (2016) Vol. 40, pp. 120-126
Closed Access | Times Cited: 117
The role of sleep deprivation and circadian rhythm disruption as risk factors of Alzheimer’s disease
Hao Wu, Sophie Dunnett, YS Ho, et al.
Frontiers in Neuroendocrinology (2019) Vol. 54, pp. 100764-100764
Closed Access | Times Cited: 116
Sleep and Cognitive Decline: A Strong Bidirectional Relationship. It Is Time for Specific Recommendations on Routine Assessment and the Management of Sleep Disorders in Patients with Mild Cognitive Impairment and Dementia
Biancamaria Guarnieri, Sandro Sorbi
European Neurology (2015) Vol. 74, Iss. 1-2, pp. 43-48
Open Access | Times Cited: 103
Biomarkers in Multiple Sclerosis: An Up-to-Date Overview
Serafeim Katsavos, Maria Anagnostouli
Multiple Sclerosis International (2013) Vol. 2013, pp. 1-20
Open Access | Times Cited: 102
Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies
Elena Urrestarazu, Jorge Iriarte
Nature and Science of Sleep (2016), pp. 21-21
Open Access | Times Cited: 102
Orexin pathway in Parkinson’s disease: a review
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 6107-6120
Closed Access | Times Cited: 23
Orexin receptors exert a neuroprotective effect in Alzheimer’s disease (AD) via heterodimerization with GPR103
Julie Davies, Jing Chen, Ryan Pink, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 69
Sleep and Neurodegeneration
Jagan A. Pillai, James B. Leverenz
CHEST Journal (2017) Vol. 151, Iss. 6, pp. 1375-1386
Closed Access | Times Cited: 65
Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk?
Claudio Liguori, Nicola Biagio Mercuri, Marzia Nuccetelli, et al.
Sleep Medicine (2019) Vol. 56, pp. 171-176
Closed Access | Times Cited: 64
Orexin and Alzheimer’s Disease
Claudio Liguori
Current topics in behavioral neurosciences (2016), pp. 305-322
Open Access | Times Cited: 63
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
Claudio Liguori, Fabio Placidi, Francesca Izzi, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 60
Achieving brain clearance and preventing neurodegenerative diseases—A glymphatic perspective
Tekla Maria Kylkilahti, Eline Berends, Marta Ramos, et al.
Journal of Cerebral Blood Flow & Metabolism (2021) Vol. 41, Iss. 9, pp. 2137-2149
Open Access | Times Cited: 48
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer’s Disease
Frank Schmidt, Jüergen Kratzsch, Hermann‐Josef Gertz, et al.
PLoS ONE (2013) Vol. 8, Iss. 5, pp. e63136-e63136
Open Access | Times Cited: 68
Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects
Ricardo S. Osorio, Emma L. Ducca, Margaret Wohlleber, et al.
SLEEP (2016) Vol. 39, Iss. 6, pp. 1253-1260
Open Access | Times Cited: 56
Sleep and hippocampal neurogenesis: Implications for Alzheimer’s disease
Brianne A. Kent, Ralph E. Mistlberger
Frontiers in Neuroendocrinology (2017) Vol. 45, pp. 35-52
Closed Access | Times Cited: 52
Arsenic Exposure Contributes to the Bioenergetic Damage in an Alzheimer’s Disease Model
Sandra A. Niño, Adriana Morales-Martínez, Érika Chi-Ahumada, et al.
ACS Chemical Neuroscience (2018) Vol. 10, Iss. 1, pp. 323-336
Closed Access | Times Cited: 52
Sleep and its regulation: An emerging pathogenic and treatment frontier in Alzheimer’s disease
Brianne A. Kent, Howard Feldman, Haakon B. Nygaard
Progress in Neurobiology (2020) Vol. 197, pp. 101902-101902
Open Access | Times Cited: 45
Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top